Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04128878 · ClinicalTrials.gov registry record
Improvement in Endothelial Dysfunction After Initiation of Anti-arrhythmic Therapy in Atrial Fibrillation Patients
A clinical trial, sponsored by Samir Saba.
- Completed
- Registry status
- 12
- Enrollment target
NCT04128878 is a clinical trial that has completed, run by Samir Saba. The registered enrollment target is 12 participants.
The verdict
NCT04128878 has completed, sponsored by Samir Saba.
- COMPLETED
- Registry status
- 12 participants
- Enrollment target
Study Summary
This is a prospective, observational study that will examine endothelial dysfunction in atrial fibrillation before and after treatment with anti-arrhythmic agents and the extent to which baseline endothelial dysfunction improves after treatment.
Interventions
- DRUG Sotalol
- DRUG Dofetilide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2019-05-01 |
| Est. Completion | 2020-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04128878
The ClinicalTrials.gov registry entry for NCT04128878 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Samir Saba, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Sotalol is the first listed.
NCT04128878 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04128878 about?
NCT04128878 is a clinical study titled "Improvement in Endothelial Dysfunction After Initiation of Anti-arrhythmic Therapy in Atrial Fibrillation Patients". This is a prospective, observational study that will examine endothelial dysfunction in atrial fibrillation before and after treatment with anti-arrhythmic agents and the extent to which baseline endothelial dysfunction improves after treatment.
What is the current status of trial NCT04128878?
This trial is currently completed. The enrollment target is 12 participants. The study started on 2019-05-01. Estimated completion is 2020-12-31.
What interventions are being tested in trial NCT04128878?
The interventions under investigation include: Sotalol (DRUG), Dofetilide (DRUG).
Who is sponsoring clinical trial NCT04128878?
This trial is sponsored by Samir Saba, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.